788 related articles for article (PubMed ID: 32126303)
1. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
Zhou Z; Sun B; Yu D; Zhu C
Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
[TBL] [Abstract][Full Text] [Related]
3. Microbiome and diabetes: Where are we now?
Vallianou NG; Stratigou T; Tsagarakis S
Diabetes Res Clin Pract; 2018 Dec; 146():111-118. PubMed ID: 30342053
[TBL] [Abstract][Full Text] [Related]
4. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
Huda MN; Kim M; Bennett BJ
Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
[TBL] [Abstract][Full Text] [Related]
5. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
6. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
Wu J; Yang K; Fan H; Wei M; Xiong Q
Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus.
Duan L; An X; Zhang Y; Jin D; Zhao S; Zhou R; Duan Y; Zhang Y; Liu X; Lian F
Biomed Pharmacother; 2021 Oct; 142():112094. PubMed ID: 34449321
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota and Complications of Type-2 Diabetes.
Iatcu CO; Steen A; Covasa M
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
[TBL] [Abstract][Full Text] [Related]
11. Restoration of dysbiotic human gut microbiome for homeostasis.
Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
Haak BW; Prescott HC; Wiersinga WJ
Front Immunol; 2018; 9():2042. PubMed ID: 30250472
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies.
Ebrahimzadeh Leylabadlo H; Ghotaslou R; Samadi Kafil H; Feizabadi MM; Moaddab SY; Farajnia S; Sheykhsaran E; Sanaie S; Shanehbandi D; Bannazadeh Baghi H
Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):613-627. PubMed ID: 31828683
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
15. Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation.
Su L; Hong Z; Zhou T; Jian Y; Xu M; Zhang X; Zhu X; Wang J
Sci Rep; 2022 Jan; 12(1):1152. PubMed ID: 35064189
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.
Sankararaman S; Noriega K; Velayuthan S; Sferra T; Martindale R
Curr Gastroenterol Rep; 2023 Feb; 25(2):31-44. PubMed ID: 36469257
[TBL] [Abstract][Full Text] [Related]
17. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
Aitbaev KA; Murkamilov IT; Fomin VV
Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
[TBL] [Abstract][Full Text] [Related]
18. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
Lee P; Yacyshyn BR; Yacyshyn MB
Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
[TBL] [Abstract][Full Text] [Related]
20. Role of Gut Microbiota in Type 2 Diabetes Mellitus and Its Complications: Novel Insights and Potential Intervention Strategies.
Woldeamlak B; Yirdaw K; Biadgo B
Korean J Gastroenterol; 2019 Dec; 74(6):314-320. PubMed ID: 31870137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
